期刊
CLINICAL AND EXPERIMENTAL DERMATOLOGY
卷 47, 期 3, 页码 611-613出版社
WILEY
DOI: 10.1111/ced.15007
关键词
-
类别
This case suggests a possible causal association between the COVID-19 vaccine and linear IgA bullous dermatosis, highlighting the importance of monitoring for immune-mediated bullous diseases following vaccination.
A case of linear IgA bullous dermatosis developing 3 days after the second dose of Oxford AstraZeneca COVID-19 vaccine in an adult patient, suggesting a possible causal association. It is worth keeping in mind that COVID-19 vaccination could induce immune-mediated bullous disease in susceptible people.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据